Wegovy
Ozempic Launches in India: Novo Nordisk's Diabetes and Weight Loss Drug Enters World's Second-Largest Diabetes Market
Dec 12, 2025 05:46 pm CST
Novo Nordisk has introduced Ozempic to the Indian market, pricing the diabetes medication at Rs 8,800-11,175 monthly across three dosages. The strategic launch targets India's significant diabetic population before generic competitors arrive in 2026. Beyond blood sugar control, Ozempic offers weight loss benefits and reduced cardiovascular risks, but remains prescription-restricted for medical use only.
Man Faints Behind President Trump During White House Drug Pricing Announcement Event
Nov 07, 2025 10:16 am CST
During a White House ceremony announcing reduced prices for popular weight-loss medications, an unexpected medical incident occurred when a pharmaceutical company representative fainted behind President Trump. The event, which featured executives from Eli Lilly and Novo Nordisk, was briefly paused before Trump revealed significant price cuts for GLP-1 medications like Wegovy and Zepbound.
Trump's 100% Pharmaceutical Tariffs: Global Impact on Countries and Companies
Sep 26, 2025 10:59 pm CST
President Trump's announcement of 100% tariffs on imported branded pharmaceuticals has sent shockwaves through the global drug industry. This policy, set to take effect in five days unless companies begin constructing US manufacturing facilities, threatens international pharmaceutical trade worth $252 billion annually. While the European Union claims protection through an existing trade agreement, countries like Switzerland and Denmark face significant risks. Pharmaceutical giants have already pledged $300 million in US investments as companies scramble to adapt to this protectionist measure that exempts generic medications but targets patented drugs.